Upcoming events

Alexandra Lansky

Interventional cardiologist / Cardiologist
Yale University School of Medicine - New Haven, United States

Latest contributions

SPOTLIGHT: Standardised definitions for clinical and imaging endpoints after surgical and transcatheter valve intervention

In this presentation from PCR London Valves 2017, A. Baumbach, D. Capodanno, A. Lansky, M.B. Leon and N. Piazza focus on the durability, structural deterioration and valve failure, the neurological adverse events and on what really matters in clinical and patient-reported endpoints after surgical and transcatheter valve interventions.

Top 3 Clinical Cases

25 Sep 2017 – From PCR London Valves 2017

Consult this session from PCR London Valves 2017 on the Top 3 Clinical cases and find out who this year's winner is between:

Percutaneous transcatheter tricuspid repair in a patient with a failing De Vega annuloplastyFirst percutaneous leadless pacemaker implantation and transcatheter tricuspid valve repair for lead-associated severe tricuspid regurgitationToolbox - Simultaneous double transseptal access for direct annuloplasty and edge-to-edge repair for treatment of severe functional mitral regurgitation

A TF TAVI with Acurate Neo valve

25 Sep 2017 – From PCR London Valves 2017

Consult this session on a TF TAVI with Acurate Neo valve, with LIVE demonstration from St Thomas' Hospital London, UK.

Clinical case
An 85-year-old with severe aortic stenosis:

- Cerebral protection
- Acurate Neo TF implanted
- Angio and TTE assessments

Reducing complications after TAVI: part II - Stroke

25 Sep 2017 – From PCR London Valves 2017

Consult this session Part II on reducing complications after TAVI - stroke if you want to learn more about:

- Long-term implications of cerebral embolism and stroke after TAVI
- Prediction and prevention: current strategies
- Prediction and prevention: future mechanical and pharmacological approaches
    

Will PIONEER AF-PCI change my practice?

19 May 2017 – From EuroPCR 2017

How to select the most appropriate treatment for long and calcified superficial femoral artery lesions

18 May 2017 – From EuroPCR 2017

Consult this session on how to select the most appropriate treatment for long and calcified superficial femoral artery lesions, that includes a LIVE demonstration from Maria Cecilia Hospital, GVM Care & Research - Cotignola, Italy.

Clinical case

A 58-year-old male with severe left leg claudication:
- SFA restenosis
- Used drug eluting balloon

Will EXCEL and NOBLE change my practice: stents or surgery for left main stem stenosis?

18 May 2017 – From EuroPCR 2017

How to treat patients with popliteal and common femoral artery lesions: new solutions for bending zones

16 May 2017 – From EuroPCR 2017

Consult this session on how to treat patients with popliteal and common femoral artery lesions, if you want to find out more about differential characteristics of devices and treatment strategies.

Will SURTAVI change my practice: TAVI for patients with intermediate risk?

16 May 2017 – From EuroPCR 2017

Will SURTAVI change my practice: TAVI for patients with intermediate risk? In this session, review the trial results for SURTAVI, learn how patient selection defines outcomes in TAVI and AVR and relate the findings of this trials to your patient population and practice.

TAVI complications and their prevention

20 Sep 2016 – From PCR London Valves 2016

Jonathan Byrne

Chairperson

Jonathan Byrne

Chairperson

Alexandra Lansky

Trials and registries 2016: what do they mean?

20 Sep 2016 – From PCR London Valves 2016

Consult this session video on the trials and registries 2016 from PCR London Valves 2016.

Martine Gilard

Chairperson

Martine Gilard
Prof. Olaf Wendler

Chairperson

Olaf Wendler

LIVE demonstration: Percutaneous edge-to-edge repair for mixed functional and degenerative mitral regurgitation using a next generation device

20 Sep 2016 – From PCR London Valves 2016

Martine Gilard

Chairperson

Martine Gilard
Prof. Olaf Wendler

Chairperson

Olaf Wendler

TAVI in a failed aortic bioprothesis

19 May 2016 – From EuroPCR 2016

Panellists: M. Balghith, A. Linke, F.J. Neumann, L. Sondergaard

Consult the session video on TAVI in a failed aortic bioprothesis, which includes a LIVE demonstration from Clinique Pasteur - Toulouse, France.

Clinical Case

A 81-year-old female with severe aortic stenosis in a failed aortic bioprothesis:

High risk of strokeCerebral protection device by radial approachNo predilatationT.F. TAVI ViV

Planned and ongoing clinical trials: a status update from genae

20 May 2015 – From EuroPCR 2015

Chairperson

Alexandra Lansky

Chairperson

Bart Segers

Will this trial change my practice? DAPT trial: 30 months of DAPT after implantation of DES

20 May 2015 – From EuroPCR 2015

Prof. Thomas Cuisset

Chairperson

Thomas Cuisset

Hot Line - PCI registries

22 May 2014 – From EuroPCR 2014

Planned and ongoing clinical trials: a status update from genae

22 May 2014 – From EuroPCR 2014

Chairperson

Alexandra Lansky

Chairperson

Bart Segers